Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
98,282,791
-
Share change
-
+6,113,531
-
Total reported value
-
$3,253,252,432
-
Put/Call ratio
-
131%
-
Price per share
-
$33.10
-
Number of holders
-
225
-
Value change
-
+$99,611,158
-
Number of buys
-
130
-
Number of sells
-
132
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q4 2016
As of 31 Dec 2016 Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) had 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 98,282,791 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, JPMORGAN CHASE & CO, VANGUARD GROUP INC, BAIN CAPITAL INVESTORS LLC, Pennant Capital Management, LLC, GOLDMAN SACHS GROUP INC, TCW GROUP INC, and BlackRock Institutional Trust Company, N.A..
This table shows 225 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.